GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Deferred Tax

Kangstem Biotech Co (XKRX:217730) Deferred Tax : ₩0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Kangstem Biotech Co's change in deferred tax for the three months ended in Dec. 2024 was ₩0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0 Mil.

Kangstem Biotech Co Deferred Tax Historical Data

The historical data trend for Kangstem Biotech Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangstem Biotech Co Deferred Tax Chart

Kangstem Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.99 15.81 -38.96 83.71 -56.13

Kangstem Biotech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Kangstem Biotech Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kangstem Biotech Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Kangstem Biotech Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangstem Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Deferred Tax
Comparable Companies
XKRX:214260 XKRX:278650 XKRX:048530 XKRX:311690 XKRX:234690 XKRX:376270 XKRX:251120 XKRX:084990 XKRX:456070 XKRX:217950 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR
Website
http://www.kangstem.com
Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Kangstem Biotech Co Headlines

No Headlines